TBHQ (Standard)
TBHQ (Standard) is the analytical standard of TBHQ. This product is intended for research and analytical applications. TBHQ (tert-Butylhydroquinone) is a widely used Nrf2 activator, protects against Doxorubicin (DOX) -induced cardiotoxicity through activation of Nrf2[1]. TBHQ (tert-Butylhydroquinone) is also an ERK activator; rescues Dehydrocorydaline (DHC) -induced cell proliferation inhibitionin melanoma[2].
Product Specifications
CAS Number
1948-33-0
Product Name Alternative
Tert-Butylhydroquinone (Standard)
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy; ERK; Ferroptosis; Keap1-Nrf2; Reference Standards
Type
Reference Standards
Related Pathways
Apoptosis; Autophagy; MAPK/ERK Pathway; NF-κB; Others; Stem Cell/Wnt
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tbhq-standard.html
Purity
99.86
Solubility
DMSO : ≥ 56.66 mg/mL
Smiles
OC1=CC=C(O)C=C1C(C)(C)C
Molecular Formula
C10H14O2
Molecular Weight
166.22
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C, sealed storage, away from light and moisture
Scientific Category
Reference Standards
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor) (VEGI/2052R), CF647 conjugate, 0.1mg/mL
